Study finds only half of patients undergoing 24-hour urine tests receive complete testingDecember 14th 2022
“One of the goals of this study was to look at whether 24-hour urine testing in the VA population included all the important components of 24-hour urine panel testing,” says Ryan Hsi, MD, FACS.
Concurrent/adjuvant ADT sequencing appears optimal in patients receiving prostate-only RTNovember 22nd 2022
“To our knowledge, this study represents the first time a significant association has been demonstrated between concurrent and adjuvant ADT sequencing and overall survival rates among prostate cancer patients," says Amar Kishan, MD.
Combined ultrasound procedure found effective in treating ureteral stonesNovember 3rd 2022
"These technologies have the potential to provide an advantageous and patient-centered solution for the gap between expectant management and urologic intervention for symptomatic ureteral stones,” says M. Kennedy Hall, MD, MHS.
Study finds inadequate patient education for scheduled urologic proceduresOctober 19th 2022
Researchers at Albert Einstein College of Medicine found patients benefited from a pre-procedural interview to educate them about the risks, benefits, and alternatives to urologic treatments they were scheduled to receive.
New machine learning tool finds link between bladder cancer and tobacco smokingOctober 11th 2022
“It doesn’t necessarily mean that you have cancer. But the more you smoke, the more mutations accumulate in your cells, and the more you increase your risk for developing cancer," said study author Marcos Díaz-Gay, PhD.
Biomarkers may be predictive of patient response to bladder cancer treatmentsOctober 6th 2022
“Our work indicates that these genetic signatures may prove to be tremendously valuable in predicting immunotherapy response in patients with bladder cancer, but also other tumor types," says Dan Theodorescu, MD, PhD.